Literature DB >> 27439306

Non-factorial analyses of two-by-two factorial trial designs.

Edward L Korn1, Boris Freidlin2.   

Abstract

BACKGROUND/AIMS: Factorial analyses of 2 × 2 trial designs are known to be problematic unless one can be sure that there is no interaction between the treatments (A and B). Instead, we consider non-factorial analyses of a factorial trial design that addresses clinically relevant questions of interest without any assumptions on the interaction. Primary questions of interest are as follows: (1) is A better than the control treatment C, (2) is B better than C, (3) is the combination of A and B (AB) better than C, and (4) is AB better than A, B, and C.
METHODS: A simple three-step procedure that tests the first three primary questions of interest using a Bonferroni adjustment at the first step is proposed. A Hochberg procedure on the four primary questions is also considered. The two procedures are evaluated and compared in limited simulations. Published results from three completed trials with factorial designs are re-evaluated using the two procedures.
RESULTS: Both suggested procedures (that answer multiple questions) require a 50%-60% increase in per arm sample size over a two-arm design asking a single question. The simulations suggest a slight advantage to the three-step procedure in terms of power (for the primary and secondary questions). The proposed procedures would have formally addressed the questions arising in the highlighted published trials arguably more simply than the pre-specified factorial analyses used.
CONCLUSION: Factorial trial designs are an efficient way to evaluate two treatments, alone and in combination. In situations where a statistical interaction between the treatment effects cannot be assumed to be 0, simple non-factorial analyses are possible that directly assess the questions of interest without the zero interaction assumption.
© The Author(s) 2016.

Keywords:  2 × 2 trial design; Factorial design; Hochberg procedure; factorial analysis; interaction; multiple comparisons

Mesh:

Year:  2016        PMID: 27439306     DOI: 10.1177/1740774516659472

Source DB:  PubMed          Journal:  Clin Trials        ISSN: 1740-7745            Impact factor:   2.486


  5 in total

Review 1.  Two-by-Two Factorial Cancer Treatment Trials: Is Sufficient Attention Being Paid to Possible Interactions?

Authors:  Boris Freidlin; Edward L Korn
Journal:  J Natl Cancer Inst       Date:  2017-09-01       Impact factor: 13.506

2.  Exercise training and NR supplementation to improve muscle mass and fitness in adolescent and young adult hematopoietic cell transplant survivors: a randomized controlled trial {1}.

Authors:  Minkeun Song; Saro H Armenian; Rusha Bhandari; Kyuwan Lee; Kirsten Ness; Mary Putt; Lanie Lindenfeld; Saro Manoukian; Kristin Wade; Anna Dedio; Tati Guzman; Isabella Hampton; Kimberly Lin; Joseph Baur; Shana McCormack; Sogol Mostoufi-Moab
Journal:  BMC Cancer       Date:  2022-07-19       Impact factor: 4.638

3.  Combining factorial and multi-arm multi-stage platform designs to evaluate multiple interventions efficiently.

Authors:  Ian R White; Babak Choodari-Oskooei; Matthew R Sydes; Brennan C Kahan; Leanne McCabe; Anna Turkova; Hanif Esmail; Diana M Gibb; Deborah Ford
Journal:  Clin Trials       Date:  2022-05-17       Impact factor: 2.599

4.  Testing Behavior Change Techniques to Encourage Primary Care Physicians to Access Cancer Screening Audit and Feedback Reports: Protocol for a Factorial Randomized Experiment of Email Content.

Authors:  Gratianne Vaisson; Holly O Witteman; Zachary Bouck; Caroline A Bravo; Laura Desveaux; Diego Llovet; Justin Presseau; Marianne Saragosa; Monica Taljaard; Shama Umar; Jeremy M Grimshaw; Jill Tinmouth; Noah M Ivers
Journal:  JMIR Res Protoc       Date:  2018-02-16

5.  Safety and Efficacy of Double Antithrombotic Therapy With Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis.

Authors:  Davide Capodanno; Marco Di Maio; Antonio Greco; Deepak L Bhatt; C Michael Gibson; Andreas Goette; Renato D Lopes; Roxana Mehran; Pascal Vranckx; Dominick J Angiolillo
Journal:  J Am Heart Assoc       Date:  2020-08-01       Impact factor: 5.501

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.